share_log
Reuters ·  Mar 11 12:30
Longeveron Inc - Trial Achieved Primary Safety and Secondary Efficacy Endpoints
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
1
Comment Comment · Views 426

Recommended

Write a comment